RJA
RDUS

Raymond James & Associates’s Radius Health, Inc. RDUS Stock Holding History

Raymond James & Associates’s Portfolio RDUS Stock Details RDUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-18,766
Closed -$553K – 3754
2018
Q2 		$553K Buy
18,766
+2,449
+15% +$77.4K ﹤0.01% 2609
2018
Q1 		$586K Buy
16,317
+1,093
+7% +$39.5K ﹤0.01% 2467
2017
Q4 		$484K Buy
15,224
+4,692
+45% +$147K ﹤0.01% 2555
2017
Q3 		$406K Buy
+10,532
New +$413K ﹤0.01% 2608
2017
Q2 		– Sell
-38,159
Closed -$1.48M – 3460
2017
Q1 		$1.48M Buy
+38,159
New +$1.6M ﹤0.01% 1729
2016
Q1 		– Sell
-12,047
Closed -$741K – 2980
2015
Q4 		$741K Buy
+12,047
New +$761K ﹤0.01% 1795

Other funds holding RDUS

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Raymond James & Associates's RDUS Position: Q3 2018 in Review

Raymond James & Associates sold out of Radius Health, Inc. (RDUS) in Q3 2018, closing a stake of 18,766 shares — an estimated $553K sold.

Raymond James & Associates first reported a position in RDUS in Q4 2015 and held it in 6 quarters. The position peaked at $1.48M in Q1 2017. 139 funds tracked by Wall St. Rank hold RDUS as of Q3 2018.

  • Raymond James & Associates reported no remaining Radius Health, Inc. position as of Q3 2018 after selling out during the quarter.
  • Raymond James & Associates sold 18,766 Radius Health, Inc. shares in Q3 2018, an estimated $553K.
  • Raymond James & Associates first reported a position in Radius Health, Inc. in Q4 2015 and held it in 6 quarters.
  • Raymond James & Associates's Radius Health, Inc. position peaked at $1.48M in Q1 2017.
  • 139 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2018.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.